Condition: HIV Infections · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
The clinical schedule will consist of 3 injections of CD40.HIVRI.Env (VRIPRO) at weeks 0, 4, and 24.40 volunteers without HIV and in overall good health, aged 18 to 60 years, who previously participated in the HVTN 706 trial.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Bridge HIV CRS | San Francisco, California, United States | Recruiting |
| The Hope Clinic of the Emory Vaccine Center CRS | Decatur, Georgia, United States | Withdrawn |
| Brigham and Women's Hospital Vaccine CRS (BWH VCRS) | Boston, Massachusetts, United States | Recruiting |
| Columbia P&S CRS | New York, New York, United States | Withdrawn |
| Penn Prevention CRS (Site ID# 30310) | Philadelphia, Pennsylvania, United States | Recruiting |
| Vanderbilt Vaccine (VV) CRS | Nashville, Tennessee, United States | Recruiting |
| Seattle Vaccine and Prevention CRS | Seattle, Washington, United States | Withdrawn |
| Via Libre CRS | Lima Cercado, Lima region, Peru | Not Yet Recruiting |
| Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS (CITBM) - Unidad de Ensayos Clínicos (UNIDEC) | Bellavista, Provincia Constitucional del Callao, Peru | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06665646